Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: Two large population-based studies

Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard

doi:10.1016/j.psyneuen.2012.08.006

Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: Two large population-based studies

Marie Kim Wium-Andersen, David Dynnes Ørsted, Børge Grønne Nordestgaard

17 Citationer (Scopus)

Abstract

OBJECTIVES: Low-grade systemic inflammation may contribute to the development of depression. We tested the hypothesis that elevated plasma levels of the inflammatory marker fibrinogen are associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in the general population. METHODS: We examined 73,367 20-100 year old men and women from two large population-based studies, the Copenhagen General Population Study and the Copenhagen City Heart Study. We measured plasma fibrinogen and recorded symptoms of psychological distress, use of antidepressant medication, and hospitalization with depression in both cross-sectional and prospective studies. RESULTS: In cross-sectional analyses, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of psychological distress, use of antidepressant medication, and hospitalization with depression (p-trend 2×10(-11) to 5×10(-95)). Furthermore, when different classes of antidepressant medication were examined, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of use of Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants (p-trend 7×10(-18) and 6×10(-7), respectively). In prospective analyses, stepwise increasing fibrinogen percentile categories also associated with stepwise increasing risk of hospitalization with depression (p-trend=7×10(-6)): age and gender adjusted hazard ratios were 1.13 (95% confidence interval 0.70-1.83) for the 25.1-50th percentiles, 1.53 (0.97-2.42) for the 50.1-75th percentiles, 1.82 (1.11-2.97) for the 75.1-90th percentiles, 2.10 (1.12-3.95) for the 90.1-95th percentiles, and 3.23 (1.79-5.85) for the >95th percentiles, versus the 0-25th percentiles. CONCLUSION: Elevated levels of fibrinogen were associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in 73,367 individuals from the general population, in cross-sectional studies and in prospective studies for hospitalization with depression.

Originalsprog	Engelsk
Tidsskrift	Psychoneuroendocrinology
Vol/bind	38
Udgave nummer	5
Sider (fra-til)	638
Antal sider	647
ISSN	0306-4530
DOI	https://doi.org/10.1016/j.psyneuen.2012.08.006
Status	Udgivet - maj 2013

Adgang til dokumentet

10.1016/j.psyneuen.2012.08.006

Citationsformater

Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression : Two large population-based studies. / Wium-Andersen, Marie Kim; Ørsted, David Dynnes; Nordestgaard, Børge Grønne.

I: Psychoneuroendocrinology, Bind 38, Nr. 5, 05.2013, s. 638.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{7388604d2a5b4463bb5f3597f8273d2e,

title = "Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: Two large population-based studies",

abstract = "OBJECTIVES: Low-grade systemic inflammation may contribute to the development of depression. We tested the hypothesis that elevated plasma levels of the inflammatory marker fibrinogen are associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in the general population. METHODS: We examined 73,367 20-100 year old men and women from two large population-based studies, the Copenhagen General Population Study and the Copenhagen City Heart Study. We measured plasma fibrinogen and recorded symptoms of psychological distress, use of antidepressant medication, and hospitalization with depression in both cross-sectional and prospective studies. RESULTS: In cross-sectional analyses, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of psychological distress, use of antidepressant medication, and hospitalization with depression (p-trend 2×10(-11) to 5×10(-95)). Furthermore, when different classes of antidepressant medication were examined, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of use of Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants (p-trend 7×10(-18) and 6×10(-7), respectively). In prospective analyses, stepwise increasing fibrinogen percentile categories also associated with stepwise increasing risk of hospitalization with depression (p-trend=7×10(-6)): age and gender adjusted hazard ratios were 1.13 (95% confidence interval 0.70-1.83) for the 25.1-50th percentiles, 1.53 (0.97-2.42) for the 50.1-75th percentiles, 1.82 (1.11-2.97) for the 75.1-90th percentiles, 2.10 (1.12-3.95) for the 90.1-95th percentiles, and 3.23 (1.79-5.85) for the >95th percentiles, versus the 0-25th percentiles. CONCLUSION: Elevated levels of fibrinogen were associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in 73,367 individuals from the general population, in cross-sectional studies and in prospective studies for hospitalization with depression.",

author = "Wium-Andersen, {Marie Kim} and {\O}rsted, {David Dynnes} and Nordestgaard, {B{\o}rge Gr{\o}nne}",

year = "2013",

month = may,

doi = "10.1016/j.psyneuen.2012.08.006",

language = "English",

volume = "38",

pages = "638",

journal = "Psychoneuroendocrinology",

issn = "0306-4530",

publisher = "Pergamon Press",

number = "5",

}

TY - JOUR

T1 - Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression

T2 - Two large population-based studies

AU - Wium-Andersen, Marie Kim

AU - Ørsted, David Dynnes

AU - Nordestgaard, Børge Grønne

PY - 2013/5

Y1 - 2013/5

N2 - OBJECTIVES: Low-grade systemic inflammation may contribute to the development of depression. We tested the hypothesis that elevated plasma levels of the inflammatory marker fibrinogen are associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in the general population. METHODS: We examined 73,367 20-100 year old men and women from two large population-based studies, the Copenhagen General Population Study and the Copenhagen City Heart Study. We measured plasma fibrinogen and recorded symptoms of psychological distress, use of antidepressant medication, and hospitalization with depression in both cross-sectional and prospective studies. RESULTS: In cross-sectional analyses, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of psychological distress, use of antidepressant medication, and hospitalization with depression (p-trend 2×10(-11) to 5×10(-95)). Furthermore, when different classes of antidepressant medication were examined, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of use of Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants (p-trend 7×10(-18) and 6×10(-7), respectively). In prospective analyses, stepwise increasing fibrinogen percentile categories also associated with stepwise increasing risk of hospitalization with depression (p-trend=7×10(-6)): age and gender adjusted hazard ratios were 1.13 (95% confidence interval 0.70-1.83) for the 25.1-50th percentiles, 1.53 (0.97-2.42) for the 50.1-75th percentiles, 1.82 (1.11-2.97) for the 75.1-90th percentiles, 2.10 (1.12-3.95) for the 90.1-95th percentiles, and 3.23 (1.79-5.85) for the >95th percentiles, versus the 0-25th percentiles. CONCLUSION: Elevated levels of fibrinogen were associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in 73,367 individuals from the general population, in cross-sectional studies and in prospective studies for hospitalization with depression.

AB - OBJECTIVES: Low-grade systemic inflammation may contribute to the development of depression. We tested the hypothesis that elevated plasma levels of the inflammatory marker fibrinogen are associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in the general population. METHODS: We examined 73,367 20-100 year old men and women from two large population-based studies, the Copenhagen General Population Study and the Copenhagen City Heart Study. We measured plasma fibrinogen and recorded symptoms of psychological distress, use of antidepressant medication, and hospitalization with depression in both cross-sectional and prospective studies. RESULTS: In cross-sectional analyses, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of psychological distress, use of antidepressant medication, and hospitalization with depression (p-trend 2×10(-11) to 5×10(-95)). Furthermore, when different classes of antidepressant medication were examined, a stepwise increase in fibrinogen percentile categories was associated with a stepwise increase in risk of use of Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants (p-trend 7×10(-18) and 6×10(-7), respectively). In prospective analyses, stepwise increasing fibrinogen percentile categories also associated with stepwise increasing risk of hospitalization with depression (p-trend=7×10(-6)): age and gender adjusted hazard ratios were 1.13 (95% confidence interval 0.70-1.83) for the 25.1-50th percentiles, 1.53 (0.97-2.42) for the 50.1-75th percentiles, 1.82 (1.11-2.97) for the 75.1-90th percentiles, 2.10 (1.12-3.95) for the 90.1-95th percentiles, and 3.23 (1.79-5.85) for the >95th percentiles, versus the 0-25th percentiles. CONCLUSION: Elevated levels of fibrinogen were associated with psychological distress, use of antidepressant medication, and with hospitalization with depression in 73,367 individuals from the general population, in cross-sectional studies and in prospective studies for hospitalization with depression.

U2 - 10.1016/j.psyneuen.2012.08.006

DO - 10.1016/j.psyneuen.2012.08.006

M3 - Journal article

C2 - 22981529

SN - 0306-4530

VL - 38

SP - 638

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

IS - 5

ER -

Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: Two large population-based studies

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater